Table of Contents
इक्विटी फंड वे हैं जिनके संचित फंड का पैसा विभिन्न कंपनियों के इक्विटी और इक्विटी से संबंधित उपकरणों में निवेश किया जाता है। मध्यम और उच्च स्तर वाले लोगों के लिए इक्विटी फंड को दीर्घकालिक निवेश विकल्प माना जाता है।जोखिम उठाने का माद्दा. इक्विटी फंड की विभिन्न श्रेणियों में शामिल हैंलार्ज कैप फंड,मिड कैप फंड,स्मॉल कैप फंड,ईएलएसएस, और इसी तरह। वर्ष 2021 में, इक्विटी बाजारों में तेजी देखी गई, जिसके कारण अधिकांश इक्विटी फंड श्रेणियों ने अच्छा प्रदर्शन किया है। इन फंडों का प्रदर्शन बहुत सारे मैक्रो और माइक्रोइकॉनॉमिक मापदंडों पर निर्भर करता है जैसे कि उद्योग का प्रदर्शन, कंपनी का प्रदर्शन, कंपनियों की कमाई और मुनाफा, इसकी भविष्य की संभावनाएं, और इसी तरह। शीर्ष औरसर्वश्रेष्ठ इक्विटी फंड वर्ष 2021 के लिए इस प्रकार हैं।
Talk to our investment specialist
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) Motilal Oswal Midcap 30 Fund Growth ₹91.3432
↓ -1.28 ₹23,704 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹43.3354
↓ -0.31 ₹763 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹44.8967
↓ -0.78 ₹3,405 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹56.2182
↓ -0.84 ₹11,172 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹151.76
↓ -1.16 ₹5,247 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹264.459
↓ -3.77 ₹1,057 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹411.043
↓ -0.58 ₹3,313 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹28.3282
↓ -0.31 ₹1,104 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹27.8136
↑ 0.11 ₹434 40 33.4 2.4 64.7 19 L&T Midcap Fund Growth ₹333.646
↓ -4.97 ₹9,541 39.7 40 1.1 30.4 19 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 1 Apr 25
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100. L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a Below is the key information for L&T Midcap Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
CAGR/Annualized
return of 22.1% since its launch. Ranked 27 in Mid Cap
category. Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (01 Apr 25) ₹91.3432 ↓ -1.28 (-1.38 %) Net Assets (Cr) ₹23,704 on 28 Feb 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 0.43 Information Ratio 0.72 Alpha Ratio 16.87 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹16,888 31 Mar 22 ₹23,342 31 Mar 23 ₹25,677 31 Mar 24 ₹41,172 31 Mar 25 ₹48,151 Returns for Motilal Oswal Midcap 30 Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Apr 25 Duration Returns 1 Month 3% 3 Month -19% 6 Month -16% 1 Year 14.2% 3 Year 26.8% 5 Year 37.3% 10 Year 15 Year Since launch 22.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 57.1% 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.41 Yr. Niket Shah 1 Jul 20 4.67 Yr. Rakesh Shetty 22 Nov 22 2.27 Yr. Sunil Sawant 1 Jul 24 0.67 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Technology 34.02% Consumer Cyclical 16.09% Industrials 11.09% Health Care 5% Communication Services 3.44% Real Estate 2.8% Basic Materials 2.32% Utility 2.06% Financial Services 0.09% Asset Allocation
Asset Class Value Cash 28.33% Equity 71.67% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE10% ₹2,349 Cr 3,190,000
↑ 340,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT10% ₹2,254 Cr 4,249,800
↑ 249,800 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL7% ₹1,619 Cr 35,027,075
↑ 26,975 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON7% ₹1,581 Cr 1,134,324
↑ 134,324 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | MAXHEALTH4% ₹975 Cr 9,969,361
↑ 1,913,231 One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 5433964% ₹934 Cr 13,066,359
↑ 3,065,359 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | 5002514% ₹873 Cr 1,800,000
↓ -820,200 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB3% ₹825 Cr 1,750,000
↓ -100,000 Bharti Hexacom Ltd (Communication Services)
Equity, Since 31 Oct 24 | BHARTIHEXA3% ₹815 Cr 6,250,000
↑ 174,429 KEI Industries Ltd (Industrials)
Equity, Since 30 Nov 24 | KEI3% ₹768 Cr 2,500,000
↑ 1,250,000 2. LIC MF Infrastructure Fund
CAGR/Annualized
return of 9% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (01 Apr 25) ₹43.3354 ↓ -0.31 (-0.72 %) Net Assets (Cr) ₹763 on 28 Feb 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 0.01 Information Ratio 0.28 Alpha Ratio 14.17 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹16,888 31 Mar 22 ₹22,193 31 Mar 23 ₹22,783 31 Mar 24 ₹36,820 31 Mar 25 ₹42,656 Returns for LIC MF Infrastructure Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Apr 25 Duration Returns 1 Month 11.4% 3 Month -16.2% 6 Month -17% 1 Year 12.8% 3 Year 23.6% 5 Year 34.2% 10 Year 15 Year Since launch 9% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.53 Yr. Mahesh Bendre 1 Jul 24 0.75 Yr. Data below for LIC MF Infrastructure Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Industrials 53.11% Basic Materials 11.98% Consumer Cyclical 9.02% Utility 8.21% Financial Services 6.04% Real Estate 2.74% Technology 2.16% Communication Services 1.9% Energy 0.74% Health Care 0.65% Asset Allocation
Asset Class Value Cash 2.97% Equity 97.03% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP5% ₹37 Cr 456,240
↑ 9,011 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006555% ₹36 Cr 94,287 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹25 Cr 724,927 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹21 Cr 571,332 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹20 Cr 332,049
↑ 536 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹20 Cr 490,363
↑ 54,480 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | 5004802% ₹18 Cr 66,848 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | 5001032% ₹18 Cr 983,002 Bharat Forge Ltd (Consumer Cyclical)
Equity, Since 30 Sep 21 | 5004932% ₹16 Cr 160,178 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹16 Cr 121,339 3. Motilal Oswal Long Term Equity Fund
CAGR/Annualized
return of 15.9% since its launch. Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% . Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (01 Apr 25) ₹44.8967 ↓ -0.78 (-1.72 %) Net Assets (Cr) ₹3,405 on 28 Feb 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 0.74 Sharpe Ratio -0.05 Information Ratio 0.52 Alpha Ratio 6.88 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹16,396 31 Mar 22 ₹18,690 31 Mar 23 ₹19,798 31 Mar 24 ₹30,510 31 Mar 25 ₹33,744 Returns for Motilal Oswal Long Term Equity Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Apr 25 Duration Returns 1 Month 8.7% 3 Month -19.8% 6 Month -18% 1 Year 7.4% 3 Year 20.8% 5 Year 28% 10 Year 15 Year Since launch 15.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.7% 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 1.22 Yr. Rakesh Shetty 22 Nov 22 2.27 Yr. Atul Mehra 1 Oct 24 0.41 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Industrials 30.18% Consumer Cyclical 22.76% Financial Services 17.97% Technology 12.09% Real Estate 6.8% Basic Materials 6.36% Health Care 2.01% Asset Allocation
Asset Class Value Cash 1.83% Equity 98.17% Top Securities Holdings / Portfolio
Name Holding Value Quantity Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433206% ₹220 Cr 9,923,692 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | 5002516% ₹206 Cr 425,260 Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials)
Equity, Since 28 Feb 23 | FLUOROCHEM4% ₹147 Cr 408,886 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | KALYANKJIL4% ₹145 Cr 3,134,622 Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER4% ₹132 Cr 235,044 Coforge Ltd (Technology)
Equity, Since 31 Jul 24 | COFORGE4% ₹124 Cr 168,355 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES4% ₹123 Cr 297,751 ICICI Bank Ltd (Financial Services)
Equity, Since 30 Nov 18 | ICICIBANK4% ₹120 Cr 995,689 Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | SUZLON4% ₹120 Cr 24,068,813 Inox Wind Ltd (Industrials)
Equity, Since 31 Dec 23 | INOXWIND4% ₹119 Cr 7,946,960 4. Motilal Oswal Multicap 35 Fund
CAGR/Annualized
return of 17.1% since its launch. Ranked 5 in Multi Cap
category. Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% . Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (01 Apr 25) ₹56.2182 ↓ -0.84 (-1.47 %) Net Assets (Cr) ₹11,172 on 28 Feb 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 0.94 Sharpe Ratio 0.34 Information Ratio 0.63 Alpha Ratio 14.54 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹16,169 31 Mar 22 ₹16,552 31 Mar 23 ₹16,009 31 Mar 24 ₹24,719 31 Mar 25 ₹29,279 Returns for Motilal Oswal Multicap 35 Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Apr 25 Duration Returns 1 Month 6.5% 3 Month -12.5% 6 Month -11.8% 1 Year 15.2% 3 Year 19.6% 5 Year 24.4% 10 Year 15 Year Since launch 17.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 45.7% 2023 31% 2022 -3% 2021 15.3% 2020 10.3% 2019 7.9% 2018 -7.8% 2017 43.1% 2016 8.5% 2015 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.41 Yr. Niket Shah 1 Jul 22 2.67 Yr. Rakesh Shetty 22 Nov 22 2.27 Yr. Atul Mehra 1 Oct 24 0.41 Yr. Sunil Sawant 1 Jul 24 0.67 Yr. Data below for Motilal Oswal Multicap 35 Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Technology 20.44% Industrials 18.3% Consumer Cyclical 17.23% Financial Services 9.73% Communication Services 9.21% Health Care 1.75% Asset Allocation
Asset Class Value Cash 23.82% Equity 76.18% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE10% ₹1,104 Cr 1,500,000
↑ 137,475 Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB8% ₹845 Cr 1,793,750
↑ 6,917 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL7% ₹809 Cr 17,500,000
↑ 250,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT7% ₹782 Cr 1,475,000
↓ -321,350 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | 5002517% ₹728 Cr 1,500,000
↓ -335,546 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN6% ₹630 Cr 4,500,000 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | 5000935% ₹601 Cr 10,500,000
↑ 4,000,000 Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 8901575% ₹558 Cr 5,000,000 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 24 | BHARTIARTL4% ₹471 Cr 3,000,000 PG Electroplast Ltd (Technology)
Equity, Since 31 Dec 24 | PGEL4% ₹397 Cr 5,000,000 5. Invesco India Mid Cap Fund
CAGR/Annualized
return of 16.4% since its launch. Ranked 38 in Mid Cap
category. Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% . Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (01 Apr 25) ₹151.76 ↓ -1.16 (-0.76 %) Net Assets (Cr) ₹5,247 on 28 Feb 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.89 Sharpe Ratio 0.25 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,622 31 Mar 22 ₹21,762 31 Mar 23 ₹21,732 31 Mar 24 ₹32,815 31 Mar 25 ₹38,891 Returns for Invesco India Mid Cap Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Apr 25 Duration Returns 1 Month 7.5% 3 Month -12.3% 6 Month -12% 1 Year 16% 3 Year 20.9% 5 Year 31.4% 10 Year 15 Year Since launch 16.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% 2015 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 1.31 Yr. Amit Ganatra 1 Sep 23 1.5 Yr. Data below for Invesco India Mid Cap Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Financial Services 23.61% Consumer Cyclical 19.8% Health Care 18.02% Technology 10.12% Basic Materials 9.73% Industrials 9.48% Real Estate 7.12% Communication Services 1.75% Asset Allocation
Asset Class Value Cash 0.35% Equity 99.65% Top Securities Holdings / Portfolio
Name Holding Value Quantity L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF4% ₹227 Cr 16,854,973 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK4% ₹222 Cr 12,506,782 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH4% ₹220 Cr 2,246,434 Dixon Technologies (India) Ltd (Technology)
Equity, Since 28 Feb 22 | DIXON4% ₹216 Cr 155,335 BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE4% ₹202 Cr 436,534 JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT4% ₹189 Cr 431,234 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | 5002514% ₹188 Cr 386,495
↑ 23,416 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE3% ₹176 Cr 1,561,354
↑ 255,695 Coforge Ltd (Technology)
Equity, Since 31 Mar 22 | COFORGE3% ₹173 Cr 234,918 Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5002713% ₹168 Cr 1,684,103 6. UTI Healthcare Fund
CAGR/Annualized
return of 14.8% since its launch. Ranked 40 in Sectoral
category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (01 Apr 25) ₹264.459 ↓ -3.77 (-1.41 %) Net Assets (Cr) ₹1,057 on 28 Feb 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.28 Information Ratio -0.09 Alpha Ratio 1.36 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,396 31 Mar 22 ₹19,596 31 Mar 23 ₹17,899 31 Mar 24 ₹27,884 31 Mar 25 ₹33,479 Returns for UTI Healthcare Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Apr 25 Duration Returns 1 Month 6.6% 3 Month -10% 6 Month -9.1% 1 Year 17% 3 Year 18.9% 5 Year 27.3% 10 Year 15 Year Since launch 14.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 2.83 Yr. Data below for UTI Healthcare Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Health Care 98.22% Basic Materials 1.33% Asset Allocation
Asset Class Value Cash 0.45% Equity 99.55% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA11% ₹116 Cr 725,000 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000876% ₹65 Cr 464,949 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹48 Cr 432,608
↓ -37,626 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323314% ₹47 Cr 188,399
↑ 1,601 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹40 Cr 309,311 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND4% ₹37 Cr 240,012
↓ -465 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹37 Cr 74,000 Suven Pharmaceuticals Ltd (Healthcare)
Equity, Since 28 Feb 21 | SUVENPHAR3% ₹36 Cr 295,000
↑ 2,080 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹34 Cr 557,701 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP3% ₹34 Cr 56,271 7. SBI Healthcare Opportunities Fund
CAGR/Annualized
return of 15.5% since its launch. Ranked 34 in Sectoral
category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (31 Mar 25) ₹411.043 ↓ -0.58 (-0.14 %) Net Assets (Cr) ₹3,313 on 28 Feb 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.35 Information Ratio 0.73 Alpha Ratio 2.13 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,177 31 Mar 22 ₹19,486 31 Mar 23 ₹19,107 31 Mar 24 ₹30,178 31 Mar 25 ₹36,162 Returns for SBI Healthcare Opportunities Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Apr 25 Duration Returns 1 Month 7.4% 3 Month -5.9% 6 Month -2% 1 Year 19.8% 3 Year 22.9% 5 Year 29.3% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.84 Yr. Data below for SBI Healthcare Opportunities Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Health Care 90.4% Basic Materials 6.89% Asset Allocation
Asset Class Value Cash 2.62% Equity 97.29% Debt 0.09% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹446 Cr 2,800,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹215 Cr 2,200,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹206 Cr 375,000
↓ -15,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹169 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY5% ₹166 Cr 300,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹160 Cr 840,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹128 Cr 560,000 Aether Industries Ltd (Basic Materials)
Equity, Since 31 May 22 | 5435344% ₹120 Cr 1,400,000 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL3% ₹115 Cr 800,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED3% ₹110 Cr 540,000
↑ 40,000 8. TATA India Pharma & Healthcare Fund
CAGR/Annualized
return of 11.9% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (01 Apr 25) ₹28.3282 ↓ -0.31 (-1.08 %) Net Assets (Cr) ₹1,104 on 28 Feb 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.04 Information Ratio 0.42 Alpha Ratio 0.96 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹16,489 31 Mar 22 ₹19,237 31 Mar 23 ₹17,775 31 Mar 24 ₹28,060 31 Mar 25 ₹32,066 Returns for TATA India Pharma & Healthcare Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Apr 25 Duration Returns 1 Month 6.6% 3 Month -11.1% 6 Month -9.1% 1 Year 11.8% 3 Year 18.3% 5 Year 26.3% 10 Year 15 Year Since launch 11.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 4.06 Yr. Rajat Srivastava 16 Sep 24 0.54 Yr. Data below for TATA India Pharma & Healthcare Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Health Care 95.87% Basic Materials 2.19% Asset Allocation
Asset Class Value Cash 1.94% Equity 98.06% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA12% ₹128 Cr 804,300 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY7% ₹80 Cr 714,555 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA7% ₹78 Cr 741,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹69 Cr 490,000 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002576% ₹69 Cr 360,240 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹58 Cr 104,965 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹52 Cr 855,100 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP4% ₹44 Cr 72,635
↑ 13,732 Zydus Lifesciences Ltd (Healthcare)
Equity, Since 31 Dec 22 | 5323214% ₹41 Cr 471,287 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM3% ₹37 Cr 906,991
↑ 250,000 9. IDBI Small Cap Fund
CAGR/Annualized
return of 14.1% since its launch. Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% . IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (01 Apr 25) ₹27.8136 ↑ 0.11 (0.40 %) Net Assets (Cr) ₹434 on 28 Feb 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio -0.14 Information Ratio -0.24 Alpha Ratio 8.11 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹19,259 31 Mar 22 ₹27,068 31 Mar 23 ₹26,914 31 Mar 24 ₹38,308 31 Mar 25 ₹42,752 Returns for IDBI Small Cap Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Apr 25 Duration Returns 1 Month 9% 3 Month -19% 6 Month -18.8% 1 Year 9.5% 3 Year 16.3% 5 Year 34.2% 10 Year 15 Year Since launch 14.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 40% 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 0.67 Yr. Mahesh Bendre 1 Jul 24 0.67 Yr. Data below for IDBI Small Cap Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Industrials 32.99% Consumer Cyclical 16.45% Basic Materials 13.18% Utility 8.02% Consumer Defensive 7.73% Financial Services 6.05% Health Care 4.12% Communication Services 2.92% Technology 2.63% Real Estate 0.83% Asset Allocation
Asset Class Value Cash 3.16% Equity 96.84% Top Securities Holdings / Portfolio
Name Holding Value Quantity JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 5346004% ₹16 Cr 2,026,866
↑ 325,507 Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO3% ₹12 Cr 752,118
↑ 198,641 International Gemmological Institute (India) Ltd (Basic Materials)
Equity, Since 31 Dec 24 | IGIL3% ₹12 Cr 303,787 Sanathan Textiles Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | SANATHAN3% ₹12 Cr 401,251
↑ 25,615 Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER3% ₹12 Cr 261,789
↑ 54,561 Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | NAVKARCORP2% ₹10 Cr 1,084,277
↑ 75,444 Himatsingka Seide Ltd (Consumer Cyclical)
Equity, Since 31 Oct 24 | 5140432% ₹10 Cr 888,863
↑ 116,168 Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 5419742% ₹10 Cr 102,604 TD Power Systems Ltd (Industrials)
Equity, Since 31 Aug 23 | TDPOWERSYS2% ₹10 Cr 316,162
↑ 24,398 Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP2% ₹10 Cr 118,679 10. L&T Midcap Fund
CAGR/Annualized
return of 18.5% since its launch. Ranked 5 in Mid Cap
category. Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% . L&T Midcap Fund
Growth Launch Date 9 Aug 04 NAV (01 Apr 25) ₹333.646 ↓ -4.97 (-1.47 %) Net Assets (Cr) ₹9,541 on 28 Feb 25 Category Equity - Mid Cap AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk High Expense Ratio 1.77 Sharpe Ratio -0.18 Information Ratio -0.34 Alpha Ratio 1.61 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Mar 20 ₹10,000 31 Mar 21 ₹17,789 31 Mar 22 ₹20,602 31 Mar 23 ₹20,542 31 Mar 24 ₹31,861 31 Mar 25 ₹34,370 Returns for L&T Midcap Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 1 Apr 25 Duration Returns 1 Month 7% 3 Month -18.8% 6 Month -18% 1 Year 4.8% 3 Year 17.8% 5 Year 28.2% 10 Year 15 Year Since launch 18.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.7% 2023 40% 2022 1.1% 2021 30.4% 2020 19% 2019 -0.2% 2018 -12% 2017 52.3% 2016 9.8% 2015 10.8% Fund Manager information for L&T Midcap Fund
Name Since Tenure Venugopal Manghat 1 Oct 23 1.42 Yr. Cheenu Gupta 26 Nov 22 2.26 Yr. Sonal Gupta 1 Oct 23 1.42 Yr. Data below for L&T Midcap Fund as on 28 Feb 25
Equity Sector Allocation
Sector Value Industrials 24.18% Consumer Cyclical 17.96% Financial Services 17.04% Technology 15.72% Health Care 12.27% Consumer Defensive 3.25% Utility 2.24% Basic Materials 1.93% Real Estate 1.54% Communication Services 1.37% Asset Allocation
Asset Class Value Cash 2.51% Equity 97.49% Top Securities Holdings / Portfolio
Name Holding Value Quantity Persistent Systems Ltd (Technology)
Equity, Since 30 Nov 22 | PERSISTENT5% ₹439 Cr 827,298 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Apr 24 | DIXON4% ₹425 Cr 304,800 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Sep 21 | MAXHEALTH4% ₹402 Cr 4,108,920
↑ 460,920 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Mar 24 | 5433204% ₹391 Cr 17,596,500 BSE Ltd (Financial Services)
Equity, Since 30 Apr 24 | BSE4% ₹371 Cr 800,300
↓ -128,758 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 May 24 | 5000934% ₹344 Cr 6,004,500
↓ -2,516,930 Indian Hotels Co Ltd (Consumer Cyclical)
Equity, Since 30 Apr 18 | 5008504% ₹342 Cr 4,782,177 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Jan 22 | FEDERALBNK4% ₹334 Cr 18,801,000 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Jun 19 | 5002513% ₹331 Cr 681,700
↑ 46,800 Coforge Ltd (Technology)
Equity, Since 31 Jul 24 | COFORGE3% ₹324 Cr 439,900